ANI Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

ANI Pharmaceuticals

10/05/2024 15:12

* ANI Pharmaceuticals Inc  ANIP.OQ  reported quarterly
adjusted
earnings of $1.21​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $1.17.  The mean expectation of five analysts
for the quarter was for earnings of $1.00 per share. Wall Street
expected results to range from 88 cents to $1.08 per share.
    * Revenue rose 28.7% to $137.43 million from a year ago;
analysts
expected $126.03 million. 
    * ANI Pharmaceuticals Inc's reported EPS for the quarter was
82
cents​.
    * The company reported quarterly net income of $17.8
million.
    * ANI Pharmaceuticals Inc shares had fallen by 4.7% this
quarter and gained 19.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for ANI
Pharmaceuticals Inc is $80.00 
This summary was machine generated from LSEG data May 10 at
02:11 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      1.00           1.21           Beat
 Dec. 31 2023      0.86           1.00           Beat
 Sep. 30 2023      0.84           1.27           Beat
 Jun. 30 2023      0.68           1.28           Beat